| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3761834
[patent_doc_number] => 05852001
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Method and compounds for inhibition of ribonucleases'
[patent_app_type] => 1
[patent_app_number] => 8/772620
[patent_app_country] => US
[patent_app_date] => 1996-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6377
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/852/05852001.pdf
[firstpage_image] =>[orig_patent_app_number] => 772620
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/772620 | Method and compounds for inhibition of ribonucleases | Dec 22, 1996 | Issued |
Array
(
[id] => 4013738
[patent_doc_number] => 05962675
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Chemical syntheses of 2\'-O-methoxy purine nucleosides'
[patent_app_type] => 1
[patent_app_number] => 8/780008
[patent_app_country] => US
[patent_app_date] => 1996-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 11978
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962675.pdf
[firstpage_image] =>[orig_patent_app_number] => 780008
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/780008 | Chemical syntheses of 2'-O-methoxy purine nucleosides | Dec 22, 1996 | Issued |
Array
(
[id] => 4064143
[patent_doc_number] => 05866548
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Caged membrane-permeant inositol phosphates'
[patent_app_type] => 1
[patent_app_number] => 8/769665
[patent_app_country] => US
[patent_app_date] => 1996-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 17446
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866548.pdf
[firstpage_image] =>[orig_patent_app_number] => 769665
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/769665 | Caged membrane-permeant inositol phosphates | Dec 18, 1996 | Issued |
Array
(
[id] => 3859911
[patent_doc_number] => 05795756
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Method and compounds for the inhibition of adenylyl cyclase'
[patent_app_type] => 1
[patent_app_number] => 8/762833
[patent_app_country] => US
[patent_app_date] => 1996-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11374
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795756.pdf
[firstpage_image] =>[orig_patent_app_number] => 762833
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/762833 | Method and compounds for the inhibition of adenylyl cyclase | Dec 9, 1996 | Issued |
Array
(
[id] => 3790159
[patent_doc_number] => 05840879
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Reagents and solid supports for improved synthesis and labeling of polynucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/761711
[patent_app_country] => US
[patent_app_date] => 1996-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8409
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840879.pdf
[firstpage_image] =>[orig_patent_app_number] => 761711
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/761711 | Reagents and solid supports for improved synthesis and labeling of polynucleotides | Dec 5, 1996 | Issued |
Array
(
[id] => 3775661
[patent_doc_number] => 05808035
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Protected nucleoside and method for its synthesis'
[patent_app_type] => 1
[patent_app_number] => 8/760591
[patent_app_country] => US
[patent_app_date] => 1996-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9097
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808035.pdf
[firstpage_image] =>[orig_patent_app_number] => 760591
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/760591 | Protected nucleoside and method for its synthesis | Dec 3, 1996 | Issued |
Array
(
[id] => 3793093
[patent_doc_number] => 05780449
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-14
[patent_title] => 'Cathepsin G-inhibiting aptamers'
[patent_app_type] => 1
[patent_app_number] => 8/753054
[patent_app_country] => US
[patent_app_date] => 1996-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3191
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/780/05780449.pdf
[firstpage_image] =>[orig_patent_app_number] => 753054
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/753054 | Cathepsin G-inhibiting aptamers | Nov 18, 1996 | Issued |
Array
(
[id] => 3860073
[patent_doc_number] => 05792773
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-11
[patent_title] => 'L-.beta.-dioxolane uridine analog administration for treating Epstein-Barr virus infection'
[patent_app_type] => 1
[patent_app_number] => 8/749263
[patent_app_country] => US
[patent_app_date] => 1996-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11690
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/792/05792773.pdf
[firstpage_image] =>[orig_patent_app_number] => 749263
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/749263 | L-.beta.-dioxolane uridine analog administration for treating Epstein-Barr virus infection | Nov 14, 1996 | Issued |
Array
(
[id] => 3828748
[patent_doc_number] => 05783689
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-21
[patent_title] => 'Antibacterial and antifungal nucleosides'
[patent_app_type] => 1
[patent_app_number] => 8/745732
[patent_app_country] => US
[patent_app_date] => 1996-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9103
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/783/05783689.pdf
[firstpage_image] =>[orig_patent_app_number] => 745732
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/745732 | Antibacterial and antifungal nucleosides | Nov 11, 1996 | Issued |
| 08/747103 | 1-(3-AMINOINDAZOL-5-YL)-3-BUTYL-CYCLIC UREA USEFUL AS A HIV PROTEASE INHIBITOR | Nov 7, 1996 | Abandoned |
Array
(
[id] => 3861159
[patent_doc_number] => 05792841
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-11
[patent_title] => '2\'-halomethylidene, 2\'-ethenylidene and 2\'-ethynl cytidine, uridine and guanosine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/744652
[patent_app_country] => US
[patent_app_date] => 1996-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13469
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/792/05792841.pdf
[firstpage_image] =>[orig_patent_app_number] => 744652
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/744652 | 2'-halomethylidene, 2'-ethenylidene and 2'-ethynl cytidine, uridine and guanosine derivatives | Nov 5, 1996 | Issued |
Array
(
[id] => 3833290
[patent_doc_number] => 05814616
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen'
[patent_app_type] => 1
[patent_app_number] => 8/744203
[patent_app_country] => US
[patent_app_date] => 1996-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7650
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814616.pdf
[firstpage_image] =>[orig_patent_app_number] => 744203
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/744203 | Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen | Nov 4, 1996 | Issued |
| 08/666525 | NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE | Oct 27, 1996 | Abandoned |
Array
(
[id] => 3775852
[patent_doc_number] => 05808047
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Process for the preparation of 2,2\'-anhydro- and 2\'-keto-1-(3\',5\'-di-O-protected-.beta.-D-arabinofuranosyl) nucleosides'
[patent_app_type] => 1
[patent_app_number] => 8/732947
[patent_app_country] => US
[patent_app_date] => 1996-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3217
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808047.pdf
[firstpage_image] =>[orig_patent_app_number] => 732947
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/732947 | Process for the preparation of 2,2'-anhydro- and 2'-keto-1-(3',5'-di-O-protected-.beta.-D-arabinofuranosyl) nucleosides | Oct 16, 1996 | Issued |
Array
(
[id] => 3769994
[patent_doc_number] => 05733890
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-31
[patent_title] => 'Adenylate analogs as potent anti-herpes virus agents'
[patent_app_type] => 1
[patent_app_number] => 8/727292
[patent_app_country] => US
[patent_app_date] => 1996-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3998
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/733/05733890.pdf
[firstpage_image] =>[orig_patent_app_number] => 727292
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727292 | Adenylate analogs as potent anti-herpes virus agents | Oct 8, 1996 | Issued |
Array
(
[id] => 4006581
[patent_doc_number] => 05859234
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => '2\'-O-methyl cytidine monomer useful in oligonucleotide synthesis'
[patent_app_type] => 1
[patent_app_number] => 8/727139
[patent_app_country] => US
[patent_app_date] => 1996-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5274
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/859/05859234.pdf
[firstpage_image] =>[orig_patent_app_number] => 727139
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727139 | 2'-O-methyl cytidine monomer useful in oligonucleotide synthesis | Oct 7, 1996 | Issued |
| 08/726098 | TREATMENT OF DISEASES CAUSED BY PARASITIC PROTOZOA AND FUNGAL DISEASES BY ADMINISTRATION OF 5 -DEOXY- 5 -(SUBSTITUTED)ETHYLTHIORIBOSE COMPOUNDS | Oct 3, 1996 | Issued |
Array
(
[id] => 3969262
[patent_doc_number] => 05886165
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-23
[patent_title] => 'Mixed backbone antisense oligonucleotides containing 2\'-5\'-ribonucleotide- and 3\'-5\'-deoxyribonucleotides segments'
[patent_app_type] => 1
[patent_app_number] => 8/719970
[patent_app_country] => US
[patent_app_date] => 1996-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 8488
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/886/05886165.pdf
[firstpage_image] =>[orig_patent_app_number] => 719970
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/719970 | Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments | Sep 23, 1996 | Issued |
| 08/707776 | 6-O-SUBSTITUTED ERYTHROMYCIN KETOLIDES HAVING ANTIBACTERIAL ACTIVITY | Sep 3, 1996 | Abandoned |
Array
(
[id] => 3888742
[patent_doc_number] => 05777099
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'RNA separation'
[patent_app_type] => 1
[patent_app_number] => 8/706260
[patent_app_country] => US
[patent_app_date] => 1996-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3723
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/777/05777099.pdf
[firstpage_image] =>[orig_patent_app_number] => 706260
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/706260 | RNA separation | Sep 3, 1996 | Issued |